Solid Biosciences Inc. (SLDB)
NASDAQ: SLDB · Real-Time Price · USD
5.66
-0.09 (-1.57%)
Nov 4, 2024, 4:00 PM EST - Market closed
Solid Biosciences Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Solid Biosciences stock have an average target of 18.11, with a low estimate of 9.00 and a high estimate of 40. The average target predicts an increase of 219.96% from the current stock price of 5.66.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 14, 2024.
Analyst Ratings
The average analyst rating for SLDB stock from 9 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 4 | 6 | 7 | 7 | 7 | 6 |
| Hold | 1 | 1 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 10 | 10 | 10 | 10 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $18 → $15 | Buy | Maintains | $18 → $15 | +165.02% | Aug 14, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $16 | Strong Buy | Reiterates | $16 | +182.69% | Aug 14, 2024 |
| JP Morgan | JP Morgan | Hold → Buy Upgrades $10 → $15 | Hold → Buy | Upgrades | $10 → $15 | +165.02% | Jul 15, 2024 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +112.01% | Jun 24, 2024 |
| Piper Sandler | Piper Sandler | Buy Reiterates $20 | Buy | Reiterates | $20 | +253.36% | Jun 21, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
382.50K
EPS This Year
-2.67
from -4.83
EPS Next Year
-2.73
from -2.67
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | 3.2M | n/a | ||
| Avg | n/a | 382,500 | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.66 | -2.18 | -1.91 | ||
| Avg | -2.67 | -2.73 | -2.79 | ||
| Low | -2.67 | -3.42 | -3.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.